{"id":"https://openalex.org/W2095996754","doi":"https://doi.org/10.1177/1087057105284340","title":"Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection\u2013Mass Spectrometry","display_name":"Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection\u2013Mass Spectrometry","publication_year":2006,"publication_date":"2006-02-20","ids":{"openalex":"https://openalex.org/W2095996754","doi":"https://doi.org/10.1177/1087057105284340","mag":"2095996754","pmid":"https://pubmed.ncbi.nlm.nih.gov/16490772"},"language":"en","primary_location":{"id":"doi:10.1177/1087057105284340","doi":"https://doi.org/10.1177/1087057105284340","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057105284340","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1177/1087057105284340","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031897645","display_name":"Charles E. Whitehurst","orcid":"https://orcid.org/0000-0003-3112-5458","observed_orcids":["https://orcid.org/0000-0003-3112-5458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles E. Whitehurst","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA 02139, USA. charles.whitehurst@spcorp.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA 02139, USA. charles.whitehurst@spcorp.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070733034","display_name":"Naim Nazef","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naim Nazef","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061797400","display_name":"D. Allen Annis","orcid":"https://orcid.org/0000-0002-3953-4590","observed_orcids":["https://orcid.org/0000-0002-3953-4590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Allen Annis","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053831043","display_name":"Yongmin Hou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongmin Hou","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Denise M. Murphy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denise M. Murphy","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038764907","display_name":"Peter Spacciapoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Spacciapoli","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046558147","display_name":"Zhiping Yao","orcid":"https://orcid.org/0000-0002-5617-5606","observed_orcids":["https://orcid.org/0000-0002-5617-5606"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiping Yao","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087839304","display_name":"Michael R. Ziebell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael R. Ziebell","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103531675","display_name":"Cliff C. Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cliff C. Cheng","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067925644","display_name":"Gerald W. Shipps","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald W. Shipps, Jr.","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068542404","display_name":"Jason S. Felsch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason S. Felsch","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Lau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Lau","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091040241","display_name":"Huw M. Nash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huw M. Nash","raw_affiliation_strings":["NeoGenesis Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeoGenesis Pharmaceuticals, Inc., Cambridge, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":1.2351,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.75448812,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"2","first_page":"194","last_page":"207"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8306000232696533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.8306000232696533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.15770000219345093,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/affinity-selection-mass-spectrometry","display_name":"affinity selection-mass spectrometry","score":0.9639999866485596},{"id":"https://openalex.org/keywords/orthosteric-antagonists","display_name":"orthosteric antagonists","score":0.7929999828338623},{"id":"https://openalex.org/keywords/allosteric-antagonists","display_name":"allosteric antagonists","score":0.8859999775886536},{"id":"https://openalex.org/keywords/n-methylscopolamine","display_name":"N-methylscopolamine","score":0.8429999947547913},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.7699999809265137},{"id":"https://openalex.org/keywords/ligand-binding-mechanism","display_name":"ligand binding mechanism","score":0.5479999780654907},{"id":"https://openalex.org/keywords/size-exclusion-chromatography","display_name":"size exclusion chromatography","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.9081311821937561},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.7175009846687317},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6440298557281494},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6400151252746582},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.594773530960083},{"id":"https://openalex.org/C64615621","wikidata":"https://www.wikidata.org/wiki/Q15333405","display_name":"Muscarinic acetylcholine receptor M5","level":5,"score":0.5263813138008118},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.5196934342384338},{"id":"https://openalex.org/C47488739","wikidata":"https://www.wikidata.org/wiki/Q17861931","display_name":"Muscarinic acetylcholine receptor M2","level":4,"score":0.49662715196609497},{"id":"https://openalex.org/C85196483","wikidata":"https://www.wikidata.org/wiki/Q6545857","display_name":"Ligand binding assay","level":3,"score":0.4942498505115509},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.47103196382522583},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.461601197719574},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4322414994239807},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.42695754766464233},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.41990044713020325},{"id":"https://openalex.org/C116289061","wikidata":"https://www.wikidata.org/wiki/Q17861955","display_name":"Muscarinic acetylcholine receptor M3","level":4,"score":0.3900444507598877},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31124570965766907}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000495","descriptor_name":"Allosteric Site","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007313","descriptor_name":"Insecta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043585","descriptor_name":"Receptor, Muscarinic M2","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D043585","descriptor_name":"Receptor, Muscarinic M2","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/1087057105284340","doi":"https://doi.org/10.1177/1087057105284340","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057105284340","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},{"id":"pmid:16490772","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16490772","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biomolecular screening","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1022.7955","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1022.7955","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jbx.sagepub.com/content/11/2/194.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1177/1087057105284340","doi":"https://doi.org/10.1177/1087057105284340","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1087057105284340","pdf_url":null,"source":{"id":"https://openalex.org/S4387277810","display_name":"SLAS DISCOVERY","issn_l":"2472-5552","issn":["2472-5552","2472-5560"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SLAS Discovery","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.46810001134872437,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W188152331","https://openalex.org/W191628672","https://openalex.org/W1226074361","https://openalex.org/W1540649941","https://openalex.org/W1578612053","https://openalex.org/W1598210821","https://openalex.org/W1603274157","https://openalex.org/W1944128994","https://openalex.org/W1995089537","https://openalex.org/W1995581477","https://openalex.org/W1997931268","https://openalex.org/W2028055843","https://openalex.org/W2030215768","https://openalex.org/W2031912568","https://openalex.org/W2034157360","https://openalex.org/W2035386743","https://openalex.org/W2040809710","https://openalex.org/W2041208984","https://openalex.org/W2042239308","https://openalex.org/W2043159065","https://openalex.org/W2045255034","https://openalex.org/W2046468487","https://openalex.org/W2064399386","https://openalex.org/W2075035957","https://openalex.org/W2086039410","https://openalex.org/W2089523547","https://openalex.org/W2094080855","https://openalex.org/W2094593442","https://openalex.org/W2095775529","https://openalex.org/W2136928794","https://openalex.org/W2155933328","https://openalex.org/W2396210193","https://openalex.org/W2415808958","https://openalex.org/W2418775721","https://openalex.org/W2553315459","https://openalex.org/W4247499156","https://openalex.org/W6712237923"],"related_works":["https://openalex.org/W7099788242","https://openalex.org/W1971209239","https://openalex.org/W4234567090","https://openalex.org/W3081149612","https://openalex.org/W7148952514","https://openalex.org/W3093626887","https://openalex.org/W1969507272","https://openalex.org/W3206352933","https://openalex.org/W3007902499","https://openalex.org/W2520646257"],"abstract_inverted_index":{"Screening":[0],"assays":[1,164],"using":[2,83],"target-based":[3],"affinity":[4],"selection":[5],"coupled":[6,87],"with":[7,136,166,179],"high-sensitivity":[8],"detection":[9],"technologies":[10],"to":[11,55,72,88,90,111,140],"identify":[12],"small-molecule":[13,57,96,181],"hits":[14],"from":[15,61,152,162,168],"chemical":[16],"libraries":[17],"can":[18],"provide":[19,185],"a":[20,80,92,105,123,186],"useful":[21,187],"discovery":[22,193],"approach":[23],"that":[24,37,176],"complements":[25],"traditional":[26],"assay":[27,189],"systems.":[28],"Affinity":[29],"selection-mass":[30],"spectrometry":[31],"(AS-MS)":[32],"is":[33,109,122,132],"one":[34],"such":[35],"methodology":[36],"holds":[38],"promise":[39],"for":[40,95,191],"providing":[41],"selective":[42],"and":[43,194],"sensitive":[44],"high-throughput":[45,188],"screening":[46,50],"platforms.":[47],"Although":[48],"AS-MS":[49,89,108,163,183],"platforms":[51],"have":[52,66],"been":[53,69],"used":[54,70,110,178],"discover":[56],"ligands":[58,97,160],"of":[59,98,116,128,150,158,196,199],"proteins":[60],"many":[62],"target":[63],"families,":[64],"they":[65],"not":[67],"yet":[68],"routinely":[71],"screen":[73,94],"integral":[74,200],"membrane":[75,201],"proteins.":[76],"The":[77,173],"authors":[78,174],"present":[79],"proof-of-concept":[81],"study":[82],"size":[84],"exclusion":[85],"chromatography":[86],"perform":[91],"primary":[93],"the":[99,113,141,147,153,159,192],"purified":[100],"muscarinic":[101],"M2":[102,129,154],"acetylcholine":[103],"receptor,":[104],"G-protein-coupled":[106],"receptor.":[107,155],"characterize":[112],"binding":[114,137],"mechanisms":[115],"2":[117],"newly":[118],"discovered":[119],"ligands.":[120],"NGD-3350":[121],"novel":[124],"M2-specific":[125],"orthosteric":[126],"antagonist":[127,143],"function.":[130],"NGD-3366":[131],"an":[133],"allosteric":[134,142,205],"ligand":[135],"properties":[138,157],"similar":[139],"W-84,":[144],"which":[145],"decreases":[146],"dissociation":[148],"rate":[149],"N-methyl-scopolamine":[151],"Binding":[156],"discerned":[161],"agree":[165],"those":[167],"in":[169],"vitro":[170],"biochemical":[171],"assays.":[172],"conclude":[175],"when":[177],"appropriate":[180],"libraries,":[182],"may":[184],"system":[190],"characterization":[195],"all":[197],"classes":[198],"protein":[202],"ligands,":[203],"including":[204],"modulators.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}